Lv7
3300 积分 2020-11-25 加入
Oral iptacopan monotherapy in paroxysmal nocturnal haemoglobinuria: final 48-week results from the open-label, randomised, phase 3 APPLY-PNH trial in anti-C5-treated patients and the open-label, single-arm, phase 3 APPOINT-PNH trial in patients previously untreated with complement inhibitors
2天前
已完结
Efficacy and Safety of Ivarmacitinib in Patients With Moderate-to-Severe, Active, Ulcerative Colitis: A Phase II Study
1个月前
已完结
Ozanimod Induction and Maintenance Treatment for Ulcerative Colitis
1个月前
已完结
Efficacy of Upadacitinib in a Randomized Trial of Patients With Active Ulcerative Colitis
1个月前
已完结
Risankizumab for Ulcerative Colitis
1个月前
已完结
Efficacy and Safety of Mirikizumab in a Randomized Phase 2 Study of Patients With Ulcerative Colitis
1个月前
已完结
Efficacy and Safety of Etrasimod in a Phase 2 Randomized Trial of Patients With Ulcerative Colitis
1个月前
已完结
Risankizumab for Ulcerative Colitis
1个月前
已完结
Etrasimod as induction and maintenance therapy for ulcerative colitis (ELEVATE): two randomised, double-blind, placebo-controlled, phase 3 studies
1个月前
已完结
Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis
1个月前
已完结
皖公网安备34019202002308
